Tooth Decay: An epidemic in America’s poorest children

by Leah Rosenbaum Last April, Dr. Paul Reggiardo saw a patient who was referred to his dental office in Huntington Beach, California from the local emergency room. She was an eight-year-old girl with facial swelling, the soft tissue on her head puffy from infection. It was facial cellulitis, said Reggiardo, caused by an infected tooth. He sees multiple cases like this each year: an untreated … Continue reading Tooth Decay: An epidemic in America’s poorest children

Should we pay for drugs or cures? How tracking drug effectiveness could improve US healthcare spending

by Dan Tarjan  figures by Krissy Lyon The EpiPen, the antiparasitic drug Daraprim, the blood pressure medication Nitropress. These life saving drugs have recently been in the news because their prices spiked by over 100% year-to-year without any apparent reason except increasing profits. And they’re not alone. Across the US healthcare industry, specialty drug prices are rising. These brand name products marked a 16.2% increase … Continue reading Should we pay for drugs or cures? How tracking drug effectiveness could improve US healthcare spending